Background: AL amyloidosis is an acquired systemic disease in which a pathologic amorphous substance produced as a result of abnormal protein metabolism is deposited in the extracellular space of various tissues.

Objectives: The aim of the study was to investigate the relationship between the kappa and lambda serum free light chains (sFLCs) and the development of AL amyloidosis in patients suffering from multiple myeloma (MM).

Material And Methods: The investigations included 70 MM patients, 40 females and 30 males, aged 28-83 years. In 37 persons, MM was had been diagnosed recently; 33 patients had been undergoing treatment. Amyloidosis was diagnosed in 18 patients (25.7%), including nine females, nine males; six had newly diagnosed disease. Fifteen patients developed kidney failure. The control group consisted of 10 healthy donors. The concentration of sFLC ls were determined using the immunonephelometric method and expressed in mg/L.

Results: In 18 MM patients with amyloidosis the concentration of κ sFLCs ranged from 0.3 to 4780 (x = 854.5, SD = 1289), and was significantly higher (p = 0.039) than in the group without amyloidosis, where the range was from 0.3 to 426.0 (x = 68.9, SD = 98.1). The highest concentration of κ sFLCs was observed in the group of five patients with amyloidosis and renal failure. The concentration of λ sFLCs in patients with amyloidosis ranged from 0.5 to 41600 (x = 3035.7, SD = 9735) and was higher than in MM patients without amyloidosis, where it ranged from 0.5 to 834.0 (x = 79.3, SD = 193). In amyloidosis patients, the concentration of λ sFLCs was significantly higher (p = 0.05) in cases of renal failure as compared with the patients with normal renal function.

Conclusions: The concentration of sFLCs is a strong indicator of amyloidosis development in MM patients.

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/23169DOI Listing

Publication Analysis

Top Keywords

concentration sflcs
20
patients amyloidosis
16
patients
13
amyloidosis
11
light chains
8
patients suffering
8
suffering multiple
8
multiple myeloma
8
amyloidosis patients
8
females males
8

Similar Publications

Article Synopsis
  • IgG4-related diseases (IgG-RDs) involve inflammation that can cause organ damage and resemble tumors, with cases also seen alongside monoclonal gammopathies (MGPs) where abnormal plasma cell growth occurs.
  • A 58-year-old man with diabetes presented symptoms like swollen lymph nodes and renal issues, leading to high levels of IgG4 and M protein detected through various lab tests.
  • After ruling out other disorders via biopsies, he was diagnosed with IgG4-RD and diabetic nephropathy, showing significant improvement after treatment with rituximab and glucocorticoids.
View Article and Find Full Text PDF

Objective: Free light chains (FLCs) can be measured in both urine (uFLC) and serum (sFLC) in immunochemistry. We aim to compare FLC levels in serum and urine assessed among healthy volunteers and measured upper reference limits (URLs) of urinary FLC to creatinine ratio (uFLC/uCr) in mg/g to compare with the manufacturer's recommended URLs.

Patients And Methods: Eligibility criteria: normal serum and urine FLC measure and negative serum/urinary immunofixation.

View Article and Find Full Text PDF

Laboratory characteristics of IgG4-related disease: A retrospective study from a single tertiary medical center.

Medicine (Baltimore)

September 2022

Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition with unique histopathological features that can affect most organs, making diagnosis challenging. This study characterized detailed laboratory characteristics of IgG4-RD. Baseline clinical and laboratory features of 33 patients with IgG4-RD were reviewed, including serum IgG4 concentrations, serum free light chains (sFLCs), IgGĸ- and IgGλ-heavy/light chains (HLCs), capillary serum protein electrophoresis (SPE), and immunofixation electrophoresis (IFE) of IgG4 subclass.

View Article and Find Full Text PDF

No Evidence of Systemic Inflammation in Symptomatic Patients With Femoroacetabular Impingement.

J Orthop Res

October 2019

Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.

Femoroacetabular impingement (FAI) is a common cause of hip pain and represents a major cause of early osteoarthritis. The role of systemic inflammation in pre-arthritic hip conditions remains largely unknown and uninvestigated. Serum-free light chains (sFLCs) are inflammatory markers produced by B cells.

View Article and Find Full Text PDF

The objective was to explore the relationship between the levels of serum and urinary free light chains (FLCs) during the progression of renal damage in multiple myeloma (MM) patients. We examined 91 cases of MM patients, detected levels of serum FLCs (sFLCs), urinary FLCs (uFLCs), and serum creatinine at the same time, and then compared sFLC and uFLC levels during normal and abnormal serum creatinine phases. Among the 91 MM patients, 22 patients had abnormal serum creatinine levels (no uremia), and 69 patients had normal serum creatinine levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!